Tibet AIM Pharm. Inc. (SHE:002826)
China · Delayed Price · Currency is CNY 17.81
-0.52 (-2.84%)
May 21, 2026, 3:04 PM CST
Tibet AIM Pharm. Market Cap
Tibet AIM Pharm. has a market cap or net worth of 3.39 billion as of May 21, 2026. Its market cap has increased by 85.62% in one year.
Market Cap
3.39B
Enterprise Value
2.86B
Revenue
670.32M
Ranking
n/a
PE Ratio
35.62
Stock Price
17.81
Market Cap Chart
Since December 9, 2016, Tibet AIM Pharm.'s market cap has increased from 1.66B to 3.39B, an increase of 104.39%. That is a compound annual growth rate of 7.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 3.48B | 1.22% |
| Dec 31, 2025 | 3.44B | 81.09% |
| Dec 31, 2024 | 1.90B | -16.02% |
| Dec 29, 2023 | 2.26B | 16.48% |
| Dec 30, 2022 | 1.94B | -7.19% |
| Dec 31, 2021 | 2.09B | 11.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Qianjiang Yongan Pharmaceutical | 3.71B |
| Nanjing Well Pharmaceutical Group | 3.65B |
| Zhejiang Cheng Yi Pharmaceutical | 3.60B |
| Huaren Pharmaceutical | 3.56B |
| Hunan Hansen Pharmaceutical | 3.56B |
| Harbin Medisan Pharmaceutical | 3.49B |
| Shanghai MicuRx Pharmaceutical | 3.43B |
| PKU HealthCare Corp.,Ltd. | 3.41B |